PIPE-791

Business-News-Today.com

Business news, market intelligence, and global industry analysis.

Business-News-Today.com

The Latest

Haleon plc invests £65M in Shanghai oral health plant as China becomes central to its global growth strategy

Haleon (NYSE, LSE: HLN) bets on China’s oral health boom with £65m Shanghai manufacturing facility

Could subcutaneous PD-1 therapy reshape oncology treatment logistics in China?

Cargo theft is rising across North America. Can Eagle Vision Security’s iFM platform stop it before it starts?

The hidden problem with GLP-1 weight loss and Veru Inc.’s bet to fix it (NASDAQ: VERU)

Contineum Therapeutics (NASDAQ: CTNM) shares slump after PIPE-307 fails to show efficacy in multiple sclerosis trial

PIPE-307 failed to meet efficacy endpoints in RRMS Phase 2, sending Contineum Therapeutics stock lower. Find out what’s next for PIPE-791 and MDD.

byVenkatesh

November 21, 2025

PIPE-791 enters clinical phase: Pipeline Therapeutics’ precision approach to neuroinflammation treatment

Pipeline Therapeutics, a clinical-stage biopharmaceutical firm specializing in precision neuroregeneration, has announced the initiation of dosing for the…

byPallavi Madhiraju

August 1, 2023

The Latest

Haleon (NYSE, LSE: HLN) bets on China’s oral health boom with £65m Shanghai manufacturing facility

Could subcutaneous PD-1 therapy reshape oncology treatment logistics in China?

Cargo theft is rising across North America. Can Eagle Vision Security’s iFM platform stop it before it starts?

The hidden problem with GLP-1 weight loss and Veru Inc.’s bet to fix it (NASDAQ: VERU)

Contineum Therapeutics (NASDAQ: CTNM) shares slump after PIPE-307 fails to show efficacy in multiple sclerosis trial

PIPE-791 enters clinical phase: Pipeline Therapeutics’ precision approach to neuroinflammation treatment

Haleon (NYSE, LSE: HLN) bets on China’s oral health boom with £65m Shanghai manufacturing facility

Could subcutaneous PD-1 therapy reshape oncology treatment logistics in China?

Cargo theft is rising across North America. Can Eagle Vision Security’s iFM platform stop it before it starts?

The hidden problem with GLP-1 weight loss and Veru Inc.’s bet to fix it (NASDAQ: VERU)

GRPN slides after Q4 revenue shortfall raises questions about Groupon’s turnaround durability

Harmony Gold Mining reports 61% operating profit surge but output decline and copper capex weigh on HMY stock

Can selective Bb inhibition give NovelMed Therapeutics an edge in the multibillion-dollar PNH drug market?

Can fewer infusions improve adherence in Fabry disease enzyme replacement therapy?